The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSirius Real Estate Regulatory News (SRE)

Share Price Information for Sirius Real Estate (SRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 93.00
Bid: 93.95
Ask: 95.05
Change: -1.20 (-1.27%)
Spread: 1.10 (1.171%)
Open: 93.00
High: 93.00
Low: 93.00
Prev. Close: 94.20
SRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

14 Jun 2019 15:10

RNS Number : 3685C
Sirius Real Estate Limited
14 June 2019
 

14 June 2019

SIRIUS REAL ESTATE LIMITED

(Incorporated in Guernsey)

Company Number: 46442

JSE Share Code: SRE

LSE (EUR) Share Code: ESRE

LSE (GBP) Share Code: SRE

ISIN Code: ISIN GG00B1W3VF54

Sirius Real Estate Limited

(the "Company")

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PDMR

Notification and public disclosure of transactions by PDMRs and persons closely associated with them.

The Company confirms that on 14 June 2019 it granted the "2019 Awards" under the Sirius Real Estate Long Term Incentive Plan 2018 (the "LTIP"), including awards granted to its Executive Directors and other Person Discharging Managerial Responsibilities.

Each award granted to the Executive Directors and other Person Discharging Managerial Responsibilities has been granted in the form of a Nil-Cost Option and consists of an "Ordinary Award" and an "Outperformance Award" as described in the circular relating to the General Meeting.

Director/PDMR

Number of shares subject to Ordinary Award

Number of shares subject to Outperformance Award

Andrew Coombs

1,200,000

300,000

Alistair Marks

1,200,000

300,000

Rüdiger Swoboda

360,000

90,000

Each award is subject to a performance condition assessed over the four financial years of the Company starting with the financial year ending 31 March 2019. Subject to the rules of the LTIP and to the satisfaction of the performance condition, the awards will vest following the assessment of the performance condition but will not be "released" until the end of a further two year holding period.

 

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Andrew Coombs

2.

Reason for the notification

a)

Position / status

Chief Executive Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Sirius Real Estate Limited

 

b)

LEI

213800NURUF5W8QSK566

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of no par value.

b)

Identification code

GB00B1W3VF54

c)

Nature of the transaction

Grant of nil-cost option over ordinary shares under the Sirius Real Estate 2018 Long Term Incentive Plan.

Mr. Coombs currently has a beneficial interest in 8,888,349 shares, representing 0.87% of the issued share capital.

d)

Price(s) and

volume(s)

Price(s)

Volume(s)

N/A

1,200,000 (Ordinary Award)

N/A

300,000 (Outperformance Award)

 

e)

Price(s) and

volume(s)

Price(s)

(p/GBP)

 

Volume(s)

Total(s)

(p/GBP)

n/a

1,200,000

Nil

n/a

300,000

Nil

 

f)

Date of the transaction

14 June 2019

g)

Place of the transaction

Outside a trading venue (off market)

h)

Nature and extent of interest in the transaction

Direct, beneficial

i)

Clearance to deal in these securities was obtained in accordance with paragraph 3.66 of the Listings Requirements of the JSE Limited.

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Alistair Marks

2.

Reason for the notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Sirius Real Estate Limited

 

b)

LEI

213800NURUF5W8QSK566

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of no par value.

b)

Identification code

GB00B1W3VF54

c)

Nature of the transaction

Grant of nil-cost option over ordinary shares under the Sirius Real Estate 2018 Long Term Incentive Plan.

Mr. Marks currently has a beneficial interest in 7,070,828 shares, representing 0.69% of the issued share capital.

d)

Price(s) and

volume(s)

Price(s)

Volume(s)

N/A

1,200,000 (Ordinary Award)

N/A

300,000 (Outperformance Award)

 

e)

Price(s) and

volume(s)

Price(s)

(p/GBP)

 

Volume(s)

Total(s)

(p/GBP)

n/a

1,200,000

Nil

n/a

300,000

Nil

 

f)

Date of the transaction

14 June 2019

g)

Place of the transaction

Outside a trading venue (off market)

h)

Nature and extent of interest in the transaction

Direct, beneficial

i)

Clearance to deal in these securities was obtained in accordance with paragraph 3.66 of the Listings Requirements of the JSE Limited.

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Rüdiger Swoboda

2.

Reason for the notification

a)

Position / status

Group Sales Director

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Sirius Real Estate Limited

 

b)

LEI

213800NURUF5W8QSK566

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of no par value.

b)

Identification code

GB00B1W3VF54

c)

Nature of the transaction

Grant of nil-cost option over ordinary shares under the Sirius Real Estate 2018 Long Term Incentive Plan.

Mr. Swoboda currently has a beneficial interest in 1,139,346 shares representing 0.11% of the issued share capital.

 

d)

Price(s) and

volume(s)

Price(s)

Volume(s)

N/A

360,000 (Ordinary Award)

N/A

90,000 (Outperformance Award)

 

e)

Price(s) and

volume(s)

Price(s)

(p/GBP)

 

Volume(s)

Total(s)

(p/GBP)

n/a

360,000

Nil

n/a

90,000

Nil

 

f)

Date of the transaction

14 June 2019

g)

Place of the transaction

Outside a trading venue (off market)

h)

Nature and extent of interest in the transaction

Direct, beneficial

i)

Clearance to deal in these securities was obtained in accordance with paragraph 3.66 of the Listings Requirements of the JSE Limited.

 

Enquiries

For further information:

 

Sirius Real Estate

Andrew Coombs, CEO

Alistair Marks, CFO

+49 (0)30 285010110

 

Tavistock

Jeremy Carey

James Verstringhe

Charlotte Dale

+44 (0)20 7920 3150

 

LEI: 213800NURUF5W8QSK566

 

JSE Sponsor

PSG Capital

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFEVRFISLIA
Date   Source Headline
15th Apr 20247:00 amRNSTrading Update
8th Apr 20247:00 amRNSSirius completes over EUR 100m of acquisitions
27th Mar 20247:00 amRNSSirius expands U.K. portfolio with acquisition
18th Mar 20243:50 pmRNSHolding(s) in Company
13th Mar 202411:00 amRNSDirector/PDMR Shareholding
12th Mar 20243:50 pmRNSStandard form for notification of major holdings
29th Feb 20247:00 amRNSSirius agrees German business park acquisition
13th Feb 20243:00 pmRNSDirector/PDMR Shareholding
9th Feb 20241:00 pmRNSResults of Dividend Reinvestment Plan
29th Jan 20241:00 pmRNSDirector/PDMR Shareholding
8th Jan 20243:00 pmRNSDirector/PDMR Shareholding
30th Nov 20233:00 pmRNSTotal Voting Rights
28th Nov 202310:00 amRNSHolding(s) in Company
21st Nov 20233:50 pmRNSDirector/PDMR Shareholding
21st Nov 20231:00 pmRNSDirector/PDMR Shareholding
20th Nov 20234:40 pmRNSResults of Capital Raise
20th Nov 20231:00 pmRNSCash dividend; Offer of Dividend Reinvestment Plan
20th Nov 20237:02 amRNSPrimaryBid Offer
20th Nov 20237:01 amRNSProposed capital raise of c. £145m
20th Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSSirius continues asset recycling programme
24th Oct 20237:00 amRNSFITCH REAFFIRMS SIRIUS’ BBB INVESTMENT RATING
9th Oct 20237:00 amRNSTrading Update
5th Oct 20234:00 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSDisposal of Kassel business park
28th Sep 20237:00 amRNSDirector/PDMR Shareholding
25th Sep 20234:00 pmRNSDirector/PDMR Shareholding
22nd Sep 20233:00 pmRNSDirector/PDMR Shareholding
7th Sep 202312:00 pmRNSDirector/PDMR Shareholding
22nd Aug 20231:10 pmRNSDirector/PDMR Shareholding
27th Jul 20237:00 amRNSUK Acquisitions Update
13th Jul 20231:00 pmRNSHolding(s) in Company
11th Jul 202312:00 pmRNSResult of AGM
30th Jun 20232:00 pmRNSTotal Voting Rights
19th Jun 20233:00 pmRNSHolding(s) in Company
14th Jun 202312:00 pmRNSDirector/PDMR Shareholding
13th Jun 20233:00 pmRNSPosting of Annual Report and Notice of AGM
12th Jun 20233:05 pmRNSDirector/PDMR Shareholding
12th Jun 20233:00 pmRNSDirector/PDMR Shareholding
8th Jun 20233:00 pmRNSAllotment of 2018 Long Term Incentive Plan Shares
6th Jun 20233:30 pmRNSDirector/PDMR Shareholding
6th Jun 20232:30 pmRNSDirector/PDMR Shareholding
5th Jun 20232:30 pmRNSDeclaration of cash dividend
5th Jun 20237:00 amRNSResults for the year ended 31 March 2023
31st May 20237:00 amRNSTrading Statement
30th May 20237:00 amRNSEARLY REFINANCING OF NEXT MAJOR DEBT EXPIRY
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSSirius completes Wuppertal business park sale
31st Mar 20234:00 pmRNSDirector/PDMR Shareholding
29th Mar 20234:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.